The impact of surgery on survival of patients with cutaneous melanoma: Revisiting the role of primary tumor excision margins

Annals of Surgery

Volumn 253, Issue 2, 2011, Pages 238-243

  Mocellin, Simone ^a   Pasquali, Sandro ^a   Nitti, Donato ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTRIBUTABLE RISK; CANCER PATIENT; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; META ANALYSIS; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN SURGERY; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW (TOPIC); TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

DISEASE-FREE SURVIVAL; HUMANS; MELANOMA; SKIN NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 79151469677     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318207a331     Document Type: Article

References (48)

1. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. Lancet. 2005;365(9460):687-701.
2. Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med. 2004;351(10):998-1012.
3. Wargo JA, Tanabe K. Surgical management of melanoma. Hematol Oncol Clin North Am. 2009;23(3):565-581, x.
4. Thompson JF, Scolyer RA, Uren RF. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am. 2006;15(2): 301-318.
5. Eggermont AM, Gore M. Randomized adjuvant therapy trials in melanoma: surgical and systemic. Semin Oncol. 2007;34(6):509-515.
6. Dummer R, Hauschild A, Pentheroudakis G. Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(suppl 4):129-131.
7. NCCN. Melanoma. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology. www.nccn.org, 2009.
8. Sutton A, Abrams K, Jones D, et al. Methods for Meta-Analysis in Medical Research. New York, NY: Wiley, 2000.
9. Borenstein M, Hedges L, Higgins J, et al. Introduction to Meta-Analysis. NewYork, NY: Wiley, 2009.
10. Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg. 2002;137(10):1101-1105.
11. Haigh PI, DiFronzo LA, McCready DR. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg. 2003;46(6):419-426.
12. Lens MB, Nathan P, Bataille V. Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg. 2007;142(9):885-891; discussion 891-893.
13. SladdenMJ, Balch C, Barzilai DA, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev. 2009;4:CD004835.
14. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535.
15. Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16.
16. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. New York, NY: Wiley, 2008.
17. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815-2834.
18. Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27(5):335-371.
19. Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long-term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer. 2000; 89(7):1495-1501.
20. Thomas JM, Newton-Bishop J, A'Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350(8):757-766.
21. Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg. 1991;126(4):438-441.
22. Balch CM, Soong SJ, Smith T, et al. Long-termresults of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol. 2001; 8(2):101-108.
23. Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer. 2003;97(8):1941-1946.
24. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999; 18(20):2693-2708.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-188.
26. Curran D, Sylvester RJ, Hoctin Boes G. Sample size estimation in phase III cancer clinical trials. Eur J Surg Oncol. 1999; 25(3):244-250.
27. Fayers PM, Machin D. Sample size: how many patients are necessary? Br J Cancer. 1995;72(1):1-9.
28. Schoenfeld DA, Richter JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics. 1982;38(1):163-170.
29. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. Bmj. 1999;319(7223): 1492-1495.
30. Ringborg U, M°ansson Brahme E, Drzewiecki K, et al. Randomized trial of a resection margin of 2 versus 4 cm for cutaneous malignant melanoma with a tumour thickness of more than 2 mm. Sixth World Congress of Melanoma. Vancouver, Canada, 2005.
31. Veronesi U, Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;318(18):1159-1162.
32. Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg. 1993;218(3):262-267; discussion 267-269.
33. Karakousis CP, Balch CM, Urist MM, et al. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol. 1996;3(5):446-452.
34. Ringborg U, Andersson R, Eldh J, et al. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group. Cancer. 1996;77(9):1809-1814.
35. Moschos S, Kirkwood JM. Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma. Cytokine Growth Factor Rev. 2007;18(5-6):451-458.
36. Fecher LA, Flaherty KT. Where are we with adjuvant therapy of stage III and IV melanoma in 2009? J Natl Compr Canc Netw. 2009;7(3): 295-304.
37. Christensen E. Methodology of superiority vs. equivalence trials and noninferiority trials. J Hepatol. 2007;46(5):947-954.
38. Altman D. Practical statistics for medical research: Chapman and Hall, 1997.
39. Hosmer D, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York, NY: Wiley, 1999.
40. Klein J,Moeschberger M. Survival analysis: techniques for censored and truncated data. London, UK: Springer, 2003.
41. Kirkwood JM, Ibrahim J, Sondak VK, et al. Use and abuse of statistics in evidence-based medicine. J Clin Oncol. 2002;20(19):4122-4123; author reply 4123-4124.
42. Satagopan JM, Ben-Porat L, Berwick M, et al. A note on competing risks in survival data analysis. Br J Cancer. 2004;91(7):1229-1235.
43. Ambrogi F, Biganzoli E, Boracchi P. Estimates of clinically useful measures in competing risks survival analysis. Stat Med. 2008;27(30):6407-6425.
44. Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res. 2007;13(2 Pt 1):559-565.
45. SEER. Surveillance Epidemiology and End Results. National Cancer Institute, USA, 2009.
46. MMMP. Melanoma Molecular Map Project. 2009.
47. Stephan C, Eisenacher M, Kohl M, et al. Proteomics data collection (ProDaC): publishing and collecting proteomics data sets in public repositories using standard formats. Methods Mol Biol. 2010;604:345-368.
48. Stokes TH, Torrance JT, Li H, et al. ArrayWiki: an enabling technology for sharing public microarray data repositories and meta-analyses. BMC Bioinformatics. 2008;9(suppl 6):S18.